期刊文献+

MMP-2和TIMP-2在肝癌中的表达及其意义 被引量:11

The significance of matrix metalIoproteinase-2 and tissue inhibitor of matrix metalIoproteinase-2 expression in human hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶-2(MMP-2)及其组织抑制剂(TIMP-2)在人肝癌组织中的表达和肝癌生物学行为之间的关系。方法:应用免疫组织化学ABC法研究了56例人肝癌组织中MMP-2和TIMP-2的表达。结果:肝癌组织中MMP-2蛋白表达阳性率为55.4%(31/56),较癌旁肝组织阳性率89.3%(50/56)明显减低(P<0.01)。包膜完整组肝癌MMP-2表达阳性率为78.6%,包膜突破组60%,无包膜组40.7%,包膜完整组与无包膜组相比有显著性差异(P<0.05)。TIMP-2在肝癌组织和癌旁肝组织中的表达阳性率分别为37.5%(21/56)和66.1%(37/56),肝癌中的表达比癌旁肝组织表达也明显降低(P<0.05)。包膜完整组肝癌TIMP-2表达阳性率为64.3%,包膜突破组为46.7%,无包膜组为18.5%,包膜完整组与无包膜组相比有显著性差异(P<0.05)。经统计学分析表明,肝癌组织中MMP-2表达与TIMP-2表达有显著相关性(P<0.05)。结论:肝癌包膜形成是抑制肿瘤浸润侵袭的重要防御反应;TIMP-2可能是通过抑制包膜的降解发挥阻遏肿瘤转移扩散的作用;降解包膜胶原成分的MMP-2及其组织抑制剂TIMP-2在癌组织中的表达状态对于判断肝癌的浸润侵袭程度有重要价值。 Objective: To evaluate the significance of matrix metalloproteinase-2 ( MMP-2 ) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) expression in human hepatocellular carcinoma (HCC) and the relationship betwwen two proteins. Methods: The expression of MMP-2 and TIMP-2 were observed in 56 cases human HCC using immunohistochemistry technique. Results; The positive rate of MMP-2 protein expression was 55.4% (21/56) in HCC, and was markedly decreased than in paratumor samples (89.3%, 50/56) (P<0.01) . The positive rate of MMP-2 protein expression in HCC, which had fibrous encasulation, incomplete encapsulation and no encapsulation, was 78.6%, 60% and 40.7% respectively. The expression rate of MMP-2 in tumors without encapsulation was significantly lower than in tumors with fibrous encapsulation( P<0.05). The positive rate of TIMP-2 protein expression in tumors and paratumor samples was 37.5% (21/56) and 66.1 % (37/56) respectively. The expression levels of TIMP-2 in HCC were significantly reduced when compared with paratumor samples. (P<0.05) The positive rate of TIMP-2 protein expression in HCC, which had fibrous encapsulation, incomplete encapsulation and no encapsulation, was 64.3%, 46.7% arid 18.5% respectively. The expression rate of TIMP-2 in tumors without encapsulation was significantly lower than that in tumors with fibrous encapsulation (P<0.05). There was a significant correlation between the expressions of MMP-2 and TIMP-2 proteins in HCC( P<0.05). Conclusion .The formation of tumor encapsulation is the main limitative reaction of tumor infiltration and invasion. It is probably that TImp-2 protein may play an important role to inhibit the disruption of fibrous encapsulation. The balanced expression of MMP-2 and TIMP-2 proteins in HCC is a significant index to predict tumor invasion and metastasis.
出处 《临床肿瘤学杂志》 CAS 2001年第1期9-12,共4页 Chinese Clinical Oncology
关键词 肝细胞癌 基质金属蛋白酶-2 金属蛋白酶组织抑制 免疫组织化学 Hepatocellular carcinoma Matrix Metalloproteinase-2 Tissue Inhibitor of Matrix Metalloproteinase-2 I mmunohistochemist ry
  • 相关文献

参考文献8

  • 1高庆,吴秉铨.基质金属蛋白酶与肿瘤侵袭和转移[J].中华病理学杂志,1998,27(2):155-156. 被引量:40
  • 2Grigioni WF, Garbisa S, Errico AD, et al. Evaluation of hepatocellular ca rcinomaaggressiveness by a panel of extracellular matrix antigens. Am J Pathol , 1991,138:647-654.
  • 3Yamamoto H, Itoh F, Adachi Y, et al. Relation of enhanced secretion of ac tiematrix metalloproteinases with tumor spread in human hepatocellular carcinom a.Gastroenterology 1997,112:1290-1296.
  • 4丛文铭,吴孟超.小肝细胞癌的临床病理特点:附93例分析[J].中华肿瘤杂志,1993,15(5):372-374. 被引量:35
  • 5Okazaki I, Wada N, Nakano M, et al. Difference in gene expression for ma t rixmetalloproteinase-1 between early and advanced hepatocellular carcinomas. Hepatology,1997,25:580-584.
  • 6Yamamoto M, Mohanam S, Sawaya R, et al. Differential expression of memra n e-typematrix metalloproteinase and its correlation with gelatinase a activatio n in humanmalignant brain tumors in vivo and in vitro. Cancer Research, 199,56:384-392.
  • 7Nuovo GJ, MacConnell PB, Simsir A, et al. Correlation of the in situ det ection ofpolymerase chain reaction-amplified metalloproteinase complementary D NAs and theirinhibitors with prognosis in cervical carcinoma. Cancer Res, 199 5,55:267-275.
  • 8Visscher DW, Hoyhtya M, Ottosen SK, et al. Enhanced expression of tissu e inhibitorof metalloproteinase(TIMP-2) in the stromal of breast carcinomas corr elates with tumorrecurrence. Int J Cancer, 1994,59:339-344.

二级参考文献5

  • 1丛文铭,肝脏,1992年,1卷,31页
  • 2丛文铭,中华肿瘤杂志,1992年,14卷,20页
  • 3丛文铭,Cancer,1990年,66卷,498页
  • 4丛文铭,中华医学杂志,1988年,68卷,463页
  • 5Chen D S,Gastroenterology,1984年,86卷,1404页

共引文献73

同被引文献104

  • 1辛永宁,宣世英,史光军,陈桦,孙樱,张健.肝癌和癌旁组织中乙型肝炎表面抗原及丙型肝炎抗原表达与肝纤维化标志物的相关性[J].中华肝脏病杂志,2005,13(7):513-515. 被引量:6
  • 2盛勤松,王琳,任锋,卢永刚,周浩,张捷.裸鼠皮下人肝癌移植瘤模型的建立[J].云南医药,2006,27(3):207-210. 被引量:1
  • 3王薇,关桂梅,孟晓婷,王淑兰.红景天素对肝癌影响的实验研究[J].白求恩医科大学学报,1997,23(1):20-22. 被引量:28
  • 4史宏男.基质金属蛋白酶在涎腺腺样囊性组织中的表达及意义[J].华西口腔医学杂志,1997,15:218-218.
  • 5李楠 徐采朴 刘为纹 等.转染金属蛋白酶抑制剂对胃癌细胞体外侵袭能力的影响[J].中国肿瘤杂志,2001,10:162-162.
  • 6Maatta M,Soini Y,Liakka A,et al.Differential expression of matrix metalloproteinase(MMP)-2,MMP-9,and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma;implications for tumor progression and clinical prognosis[J].Clin Cancer Res,2000;6(7):2726-2734.
  • 7Yamamoto H.Itoh F,Adachi Y,et al.Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma[J].Gastroenterology,1997;112(4):1290-1296.
  • 8Rossello A,Nuti E,Orlandini E,et al.New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A(MMP-2)[J].Bioorg Med Chem,2004; 12(9):2441-2450.
  • 9Levitt NC,Eskens FA,O'Byrne KJ,et al.Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor,MMI270(CGS27023A),in patients with advanced solid cancer[J].Clin Cancer Res,2001;7(7):1912-1922.
  • 10Li YL,Xu WF.Design,synthesis,and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors[J].Bioorg Med Chem,2004;12(19);5171-5180.

引证文献11

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部